The Hartford Healthcare Fund Class Y (HGHYX)

Fund Assets	786.42M
Expense Ratio	1.051%
Min. Investment	$250,000
Turnover	40.00%
Dividend (ttm)	n/a
Dividend Yield	n/a
Dividend Growth	n/a
Payout Frequency	n/a
Ex-Dividend Date	Dec 11, 2025

Previous Close	55.29
YTD Return	12.28%
1-Year Return	22.91%
5-Year Return	21.63%
52-Week Low	44.75
52-Week High	55.77
Beta (5Y)	0.61
Holdings	88
Inception Date	May 1, 2000

About HGHYX

The Hartford Healthcare Fund Class Y is a mutual fund dedicated to achieving long-term capital appreciation by investing primarily in the global healthcare sector. Managed by Wellington Management Company LLP, the fund allocates at least 80% of its assets to equity securities of companies involved in various healthcare industries, including pharmaceuticals, biotechnology, medical devices, medical services, managed care, and health information services. This broad approach encompasses both established and emerging segments within the healthcare field, allowing the fund to capture diverse growth opportunities. The fund is classified as an institutional share class, with a minimum investment requirement of $250,000 and an expense ratio of 1.03%. Its portfolio is diversified across market capitalizations but is notably weighted toward large and giant cap healthcare firms such as Eli Lilly and UnitedHealth Group. The Hartford Healthcare Fund Class Y has approximately 100 holdings and distributes dividends annually, providing exposure to both domestic and international healthcare innovations. Its role in the financial market centers on offering targeted sector exposure, facilitating diversification for investors seeking participation in the growth and resilience of the global healthcare industry.

• Fund Family: Hartford Mutual Funds
• Category: Health
• Performance Rating: Average
• Risk Rating: Average
• Stock Exchange: Nasdaq
• Ticker Symbol: HGHYX
• Share Class: Class Y
• Index: S&P Composite 1500 Health Care TR

Performance

HGHYX had a total return of 22.91% in the past year, including dividends. Since the fund's inception, the average annual return has been 11.07%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
HGHVX	Class R6	0.94%
HGHFX	Class F	0.94%
HGHIX	Class I	1.05%
HGHTX	Class R5	1.06%

Top 10 Holdings

47.14% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	11.62%
Johnson & Johnson	JNJ	6.71%
Merck & Co., Inc.	MRK	6.42%
AbbVie Inc.	ABBV	4.33%
UnitedHealth Group Incorporated	UNH	4.27%
Elevance Health, Inc.	ELV	3.00%
Intuitive Surgical, Inc.	ISRG	2.94%
Vertex Pharmaceuticals Incorporated	VRTX	2.89%
CVS Health Corporation	CVS	2.64%
Edwards Lifesciences Corporation	EW	2.32%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 11, 2025	$1.40315	Dec 12, 2025
Dec 27, 2024	$0.14994	Dec 30, 2024
Dec 11, 2024	$1.89862	Dec 12, 2024
Dec 12, 2022	$0.36137	Dec 13, 2022
Dec 10, 2021	$4.37361	Dec 13, 2021
Dec 10, 2020	$5.16605	Dec 11, 2020

Data Sources: Tiingo, Financial Modeling Prep, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Financial Modeling Prep. Several fund data points are also provided by Finnhub.

Last checked:

Oct 25, 2026

Data Sources Report a data error